Literature DB >> 7059869

Adverse neurologic effects of metoclopramide.

J D Grimes, M N Hassan, D N Preston.   

Abstract

Metoclopramide hydrochloride is now commonly prescribed for a variety of gastrointestinal disorders. Over a 2-year period 18 patients with neurologic disorders induced by metoclopramide were assessed at the Parkinson's disease clinic of the Ottawa Civic Hospital. During metoclopramide therapy acute transient dystonic reactions were seen in 4 patients, and parkinsonism, which was frequently misdiagnosed and treated as classic Parkinson's disease, was seen in 12 patients. After treatment with metoclopramide was stopped, tardive dyskinesia appeared in seven patients and has persisted for up to 15 months in three patients. Parkinsonism and tardive dyskinesia occurred in older patients undergoing long-term therapy with metoclopramide. This experience, therefore, suggests that such treatment, especially in older patients, should be avoided.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059869      PMCID: PMC1862808     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  Drug-induced neurological disease.

Authors:  E M Critchley
Journal:  Br Med J       Date:  1979-03-31

2.  Metoclopramide in Parkinson's disease.

Authors:  D N Bateman; C Kahn; N J Legg; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

3.  Dystonic reactions due to metoclopramide and phenothiazines resembling tetanus.

Authors:  D L Cochlin
Journal:  Br J Clin Pract       Date:  1974-06

4.  Dystonic reactions in children caused by metoclopramide.

Authors:  M Casteels-Van Daele; J Jaeken; P Van der Schueren; P Van den Bon
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

5.  Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.

Authors:  D Tarsy; J D Parkes; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

6.  Extrapyramidal side-effects of metoclopramide.

Authors:  M Kataria; M Traub; C D Marsden
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

7.  Tardive dyskinesia.

Authors:  R H Ehrensing
Journal:  Arch Intern Med       Date:  1978-08

8.  Lecithin can suppress tardive dyskinesia.

Authors:  J H Growdon; A J Gelenberg; J Doller; M J Hirsch; R J Wurtman
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

9.  Metoclopramide induced dystonic reactions misdiagnosed as hysteria.

Authors:  T K Daneshmend; A P Manning
Journal:  Br J Clin Pract       Date:  1978-11

10.  Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.

Authors:  L Ahtee
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

View more
  19 in total

Review 1.  Risks and benefits of drugs used in the management of postoperative nausea and vomiting.

Authors:  Y F Sung
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  Withdrawal effects of metoclopramide.

Authors:  A M Noll; D Pinsky
Journal:  West J Med       Date:  1991-06

3.  Acute dystonia mimicking angioedema of the tongue: a video-illustrated case.

Authors:  Eva Rye Rasmussen; Kristine A U Pallesen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2013-07-08

4.  Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent.

Authors:  Maryam Karimi Khaledi; Katie J Suda; Chasity M Shelton
Journal:  Int J Clin Pharm       Date:  2012-08-09

5.  Acute dystonic reaction with asterixis and myoclonus following metoclopramide therapy.

Authors:  C S Lu; N S Chu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

6.  Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.

Authors:  J D Grimes
Journal:  Can Med Assoc J       Date:  1982-03-01       Impact factor: 8.262

7.  Metoclopramide and tardive dyskinesia in the elderly.

Authors:  M L Orme; R C Tallis
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

8.  Neuroleptic malignant syndrome associated with metoclopramide.

Authors:  M B Robinson; R P Kennett; A E Harding; N J Legg; B Clarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 9.  Practical aspects of drug treatment in elderly patients with mobility problems.

Authors:  J H Thwaites
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 10.  Nonulcer dyspepsia.

Authors:  W G Thompson
Journal:  Can Med Assoc J       Date:  1984-03-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.